ArticleClinical and translational medicine2022

Kindlin-1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types.

Paula Azorin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.